Research and Development Team

The Research and Development Team at Cardiff Oncology is responsible for innovating and advancing the company's lead candidate, onvansertib. This team focuses on exploring combinatorial therapies using onvansertib with standard-of-care chemotherapy and targeted therapeutics, conducting preclinical and clinical research, analyzing genomic data to understand treatment responses, managing clinical trials, and ensuring the progression of development programs to overcome cancer resistance and improve patient outcomes.